Nanobiotix (NBTX) Institutional Ownership $2.98 0.00 (0.00%) (As of 11:04 AM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Nanobiotix (NASDAQ:NBTX)CurrentInstitutional OwnershipPercentage38.81%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$6.79MNumber ofInstitutional Sellers(last 12 months)0 Get NBTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Nanobiotix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NBTX Institutional Buying and Selling by Quarter Ad Prosper Trading AcademyA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading system finds high-probability option trades in less than 60 seconds a dayClick HERE to access this powerful AI Trading System Nanobiotix Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/26/2024 Baillie Gifford & Co.2,869,030$20.89M0.0%+48.2%6.087% 11/13/2023 Baillie Gifford & Co.1,936,195$16.94M0.0%+38.3%5.350% 11/9/2023 Johnson & Johnson959,637$8.40M3.1%N/A2.652% 8/17/2021 Woodline Partners LP59,994$827K0.0%-7.0%0.174% 5/18/2021 Millennium Management LLC22,082$332K0.0%-53.3%0.066% 5/17/2021 Perceptive Advisors LLC1,059,800$15.94M0.2%-3.7%3.043% 5/17/2021 Woodline Partners LP64,514$970K0.0%-7.8%0.194% 5/12/2021 UBS Group AG70,182$1.06M0.0%+20,183.8%0.211% 2/16/2021 Orbimed Advisors LLC500,000$8.25M0.1%N/A1.500% 2/11/2021 Artal Group S.A.1,000,000$16.50M0.4%N/A2.999% 2/11/2021 Monashee Investment Management LLC15,000$248K0.0%N/A0.045% 2/11/2021 Tybourne Capital Management HK Ltd.750,000$12.38M0.3%N/A2.250% 2/10/2021 Baillie Gifford & Co.1,400,000$23.10M0.0%N/A4.199% (Data available from 1/1/2016 forward) NBTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NBTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Nanobiotix shares: Baillie Gifford & Co. ($20.89M), Johnson & Johnson ($8.40M).Learn more on NBTX's institutional investors. What percentage of Nanobiotix stock is owned by institutional investors? 38.81% of Nanobiotix stock is owned by institutional investors. Learn more on NBTX's institutional investor holdings. Which institutional investors have been buying Nanobiotix stock? The following institutional investors have purchased Nanobiotix stock in the last 24 months: Baillie Gifford & Co. ($1.47M), and Johnson & Johnson ($959.64K). How much institutional buying is happening at Nanobiotix? Institutional investors have bought a total of 2,428,667 shares in the last 24 months. This purchase volume represents approximately $19.88M in transactions. Related Companies Terns Pharmaceuticals Institutional Ownership ORIC Pharmaceuticals Institutional Ownership Phathom Pharmaceuticals Institutional Ownership Tourmaline Bio Institutional Ownership Ginkgo Bioworks Institutional Ownership ProKidney Institutional Ownership Astria Therapeutics Institutional Ownership Humacyte Institutional Ownership Annexon Institutional Ownership PureTech Health Institutional Ownership This page (NASDAQ:NBTX) was last updated on 12/24/2024 by MarketBeat.com Staff From Our Partners"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | SponsoredA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTiny Mineral, Massive Market OpportunityImagine a mineral so small it fits in the palm of your hand... yet its potential could transform the world's f...i2i Marketing Group, LLC | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanobiotix S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nanobiotix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NBTX Stock Alerts